NO784325L - Analogifremgangsmaate for fremstilling av farmasoeytisk aktive tetracyklononanderivater - Google Patents

Analogifremgangsmaate for fremstilling av farmasoeytisk aktive tetracyklononanderivater

Info

Publication number
NO784325L
NO784325L NO784325A NO784325A NO784325L NO 784325 L NO784325 L NO 784325L NO 784325 A NO784325 A NO 784325A NO 784325 A NO784325 A NO 784325A NO 784325 L NO784325 L NO 784325L
Authority
NO
Norway
Prior art keywords
tetracyclononan
derivatives
preparation
pharmaceutical active
analogical procedure
Prior art date
Application number
NO784325A
Other languages
English (en)
Other versions
NO149471C (no
NO149471B (no
Inventor
Douglas Lintin Swallow
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of NO784325L publication Critical patent/NO784325L/no
Publication of NO149471B publication Critical patent/NO149471B/no
Publication of NO149471C publication Critical patent/NO149471C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
    • C07C217/84—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/16—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings
    • C07C211/19—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings containing condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/45—Monoamines
    • C07C211/48—N-alkylated amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/52—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/86—Ring systems containing bridged rings containing four rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NO784325A 1977-12-22 1978-12-21 Analogifremgangsmaate for fremstilling av farmasoeytisk aktive tetracyklononanderivater NO149471C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5344677 1977-12-22

Publications (3)

Publication Number Publication Date
NO784325L true NO784325L (no) 1979-07-27
NO149471B NO149471B (no) 1984-01-16
NO149471C NO149471C (no) 1984-04-25

Family

ID=10467839

Family Applications (1)

Application Number Title Priority Date Filing Date
NO784325A NO149471C (no) 1977-12-22 1978-12-21 Analogifremgangsmaate for fremstilling av farmasoeytisk aktive tetracyklononanderivater

Country Status (20)

Country Link
US (2) US4357352A (no)
EP (1) EP0002896B1 (no)
JP (1) JPS5490167A (no)
AT (1) AT363923B (no)
AU (1) AU517387B2 (no)
CA (1) CA1118792A (no)
CS (1) CS208769B2 (no)
DD (1) DD140843A5 (no)
DE (1) DE2861796D1 (no)
DK (1) DK150299C (no)
ES (1) ES476241A1 (no)
FI (1) FI66347C (no)
HU (1) HU177222B (no)
IL (1) IL56167A (no)
IT (1) IT1110868B (no)
NO (1) NO149471C (no)
NZ (1) NZ189087A (no)
PT (1) PT68974A (no)
SU (1) SU1156591A3 (no)
YU (1) YU40544B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA822158B (no) * 1980-12-30 1984-10-01
US4668703A (en) * 1983-07-07 1987-05-26 Syntex (U.S.A.) Inc. γ-allenyl-γ-aminobutyric acids
JPS63188770U (no) * 1987-05-25 1988-12-05
US5414011A (en) * 1987-09-11 1995-05-09 Syntex (U.S.A.) Inc. Preservative system for ophthalmic formulations
US6150398A (en) * 1991-05-08 2000-11-21 The United States Of America As Represented By The Department Of Health And Human Services Methods for the treatment of cancer
US5645988A (en) * 1991-05-08 1997-07-08 The United States Of America As Represented By The Department Of Health And Human Services Methods of identifying drugs with selective effects against cancer cells
US20030225044A1 (en) * 2002-06-03 2003-12-04 Bachman Stephen E. Method to increase serum levels of vitamins in animals including humans

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3418368A (en) * 1965-03-24 1968-12-24 Smith Kline French Lab Pentacyclo[6.2.0.02,6.03,10.05,9] decaneamines
US3456008A (en) * 1965-10-11 1969-07-15 Smithkline Corp Aminopolycyclodecanes
CH472364A (de) 1966-12-22 1969-05-15 Geigy Ag J R Verfahren zur Herstellung eines neuen polycyclischen Amins
US3496228A (en) * 1967-02-16 1970-02-17 Smithkline Corp Aminotricyclononanes and the salts thereof

Also Published As

Publication number Publication date
NZ189087A (en) 1980-11-14
US4454157A (en) 1984-06-12
CS208769B2 (en) 1981-09-15
NO149471C (no) 1984-04-25
FI783948A7 (fi) 1979-06-23
DK150299C (da) 1987-10-26
DD140843A5 (de) 1980-04-02
YU40544B (en) 1986-02-28
DE2861796D1 (en) 1982-06-24
IT7852360A0 (it) 1978-12-19
PT68974A (en) 1979-01-01
IL56167A (en) 1982-09-30
SU1156591A3 (ru) 1985-05-15
JPS6214539B2 (no) 1987-04-02
FI66347C (fi) 1984-10-10
EP0002896B1 (en) 1982-05-05
CA1118792A (en) 1982-02-23
DK560278A (da) 1979-06-23
AU517387B2 (en) 1981-07-30
ATA913078A (de) 1981-02-15
HU177222B (en) 1981-08-28
JPS5490167A (en) 1979-07-17
YU303778A (en) 1983-01-21
US4357352A (en) 1982-11-02
NO149471B (no) 1984-01-16
ES476241A1 (es) 1979-04-16
FI66347B (fi) 1984-06-29
DK150299B (da) 1987-02-02
AT363923B (de) 1981-09-10
AU4224178A (en) 1979-06-28
IL56167A0 (en) 1979-03-12
IT1110868B (it) 1986-01-06
EP0002896A1 (en) 1979-07-11

Similar Documents

Publication Publication Date Title
NO784211L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive acylanilid-derivater
NO784231L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive benzotiazinderivater
NO784397L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater
NO148148C (no) Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater
NO782127L (no) Fremgangsmaate for fremstilling av fysiologisk aktive isoksazolo-pyridin-derivater
NO155774C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater.
NO145657C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkenderivater.
NO773384L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO780883L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive 4-acylamino-fenyl-etanolaminer
NO800881L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
NO792404L (no) Fremgangsmaate for fremstilling av imidazolderivater
NO782756L (no) Fremgangsmaate for fremstilling av terapeutisk aktive antrakinonderivater
NO781880L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater
NO146865C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 16-dehydro-androstanderivater
NO773327L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive pyrazolopyridiner
NO834363L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sesquiterpenderivater
NO780214L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive aminoalkoksyfenylderivater
NO790523L (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive 2-fenyliminoimidazolidiner
NO781879L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO149314C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive imidazoisokinolindioner
NO780743L (no) Fremgangsmaate for fremstilling av farmakologisk aktive benzylpyrimidiner
NO780644L (no) Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater
NO794318L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater
NO782767L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyletanolaminderivater
NO773344L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive pyridobenzodiazepinoner